Static Chart Pfizer Inc.

Equities

Market Closed - Nyse Other stock markets 21:03:13 05/06/2026 BST			5-day change	1st Jan Change
26.04 ^USD	+1.36%		-0.53%	+4.58%

06-06	Pfizer Presents Detailed Results From Multiple Phase 2b Studies Of Berobenatide And Plans To Advance 10 Phase 3 Studies For Chronic Weight Management And Obesity-Related Comorbidities	CI
06-06	Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial	RE

Duration

Period